Download PDF
Int J Angiol 2015; 24(03): 173-178
DOI: 10.1055/s-0035-1554910
Invited Paper
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Assessment of Carotid Artery Stenosis and the Use of Statins

Thomas F. Whayne Jr
1   Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, Kentucky
› Author Affiliations
Further Information

Publication History

Publication Date:
05 June 2015 (online)

   Permissions and Reprints

Abstract

General thinking has previously centered on managing carotid artery stenosis (CAS) by carotid endarterectomy and subsequently, stenting for higher risk patients. However for CAS and other forms of vascular disease, especially when asymptomatic, there is new emphasis on defining underlying mechanisms. Knowledge of these mechanisms can lead to medical treatments that result in possible atherosclerotic plaque stabilization, and even plaque regression, including in the patient with CAS. For now, the key medication class for a medical approach are the statins. Their use is supported by good cardiovascular clinical trial evidence including some directed carotid artery studies, especially with a demonstrated decrease in carotid intima-media thickness. Procedural controversy still exists but the current era in medicine offers significant support for medical management of asymptomatic CAS while techniques to recognize the vulnerable plaque evolve. If CAS converts to a symptomatic status, early referral for endarterectomy or stenting is indicated.

Keywords

atherosclerosis - cardiovascular risk - carotid artery stenosis - coronary heart disease - peripheral arterial disease - peripheral vascular disease - prevention - statins
 

  • References

  • 1 Hiatt WR, Goldstone J, Smith Jr SC , et al; American Heart Association Writing Group 1. Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases. Circulation 2008; 118 (25) 2826-2829
    CrossrefPubMedGoogle Scholar
  • 2 American Heart Association. What Is Peripheral Vascular Disease?. Available at: http://www.heart.org/idc/groups/heart-public/@wcm/@hcm/documents/downloadable/ucm_300323.pdf . Accessed January 30, 2015
    PubMedGoogle Scholar
  • 3 Rooke TW, Hirsch AT, Misra S , et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society for Vascular Medicine; Society for Vascular Surgery. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. J Vasc Surg 2011; 54 (5) e32-e58
    CrossrefPubMedGoogle Scholar
  • 4 Stansby G, Mister R, Fowkes G , et al; Prospective Registry and Evaluation of Peripheral Arterial Risks, Events and Distribution Investigators. High risk of peripheral arterial disease in the United Kingdom: 2-year results of a prospective registry. Angiology 2011; 62 (2) 111-118
    CrossrefPubMedGoogle Scholar
  • 5 Mukherjee D, Lingam P, Chetcuti S , et al. Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2). Circulation 2002; 106 (15) 1909-1912
    CrossrefPubMedGoogle Scholar
  • 6 Shah AM, Banerjee T, Mukherjee D. Coronary, peripheral and cerebrovascular disease: a complex relationship. J Indian Med Assoc 2010; 108 (5) 292-294 , 296
    PubMedGoogle Scholar
  • 7 Mukherjee D, Cho L. Peripheral arterial disease: considerations in risks, diagnosis, and treatment. J Natl Med Assoc 2009; 101 (10) 999-1008
    PubMedGoogle Scholar
  • 8 Takigawa M, Yoshimuta T, Akutsu K, Takeshita S, Yokoyama N. Prevalence and predictors of coexistent silent atherosclerotic cardiovascular disease in patients with abdominal aortic aneurysm without previous symptomatic cardiovascular diseases. Angiology 2012; 63 (5) 380-385
    CrossrefPubMedGoogle Scholar
  • 9 Paraskevas KI, Mikhailidis DP, Liapis CD. Internal carotid artery occlusion: association with atherosclerotic disease in other arterial beds and vascular risk factors. Angiology 2007; 58 (3) 329-335
    CrossrefPubMedGoogle Scholar
  • 10 Badheka AO, Rathod AD, Bharadwaj AS , et al. Outcomes and risk prediction model for peripheral arterial disease in patients with stable coronary artery disease. Angiology 2011; 62 (6) 473-479
    CrossrefPubMedGoogle Scholar
  • 11 Levin LA, Mootha VV. Postprandial transient visual loss. A symptom of critical carotid stenosis. Ophthalmology 1997; 104 (3) 397-401
    CrossrefPubMedGoogle Scholar
  • 12 Gupta A, Chazen JL, Hartman M , et al. Cerebrovascular reserve and stroke risk in patients with carotid stenosis or occlusion: a systematic review and meta-analysis. Stroke 2012; 43 (11) 2884-2891
    CrossrefPubMedGoogle Scholar
  • 13 Tardif JC, Spence JD, Heinonen TM , et al. Atherosclerosis imaging and the Canadian Atherosclerosis Imaging Network. Can J Cardiol 2013; 29 (3) 297-303
    CrossrefPubMedGoogle Scholar
  • 14 Wardlaw JM, Chappell FM, Stevenson M , et al. Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Technol Assess 2006; 10 (30) iii-iv , ix–x, 1–182
    PubMedGoogle Scholar
  • 15 Chaer RA, DeRubertis B, Patel S, Lin SC, Kent CK, Faries PL. Current management of extracranial carotid artery disease. Rev Recent Clin Trials 2006; 1 (3) 293-301
    CrossrefPubMedGoogle Scholar
  • 16 Kohler TR, Nance DR, Cramer MM, Vandenburghe N, Strandness Jr DE. Duplex scanning for diagnosis of aortoiliac and femoropopliteal disease: a prospective study. Circulation 1987; 76 (5) 1074-1080
    CrossrefPubMedGoogle Scholar
  • 17 Whelan JF, Barry MH, Moir JD. Color flow Doppler ultrasonography: comparison with peripheral arteriography for the investigation of peripheral vascular disease. J Clin Ultrasound 1992; 20 (6) 369-374
    CrossrefPubMedGoogle Scholar
  • 18 Allard L, Cloutier G, Durand LG, Roederer GO, Langlois YE. Limitations of ultrasonic duplex scanning for diagnosing lower limb arterial stenoses in the presence of adjacent segment disease. J Vasc Surg 1994; 19 (4) 650-657
    CrossrefPubMedGoogle Scholar
  • 19 Debrey SM, Yu H, Lynch JK , et al. Diagnostic accuracy of magnetic resonance angiography for internal carotid artery disease: a systematic review and meta-analysis. Stroke 2008; 39 (8) 2237-2248
    CrossrefPubMedGoogle Scholar
  • 20 Gupta A, Baradaran H, Schweitzer AD , et al. Carotid plaque MRI and stroke risk: a systematic review and meta-analysis. Stroke 2013; 44 (11) 3071-3077
    CrossrefPubMedGoogle Scholar
  • 21 Zhang Y, Guallar E, Qiao Y, Wasserman BA. Is carotid intima-media thickness as predictive as other noninvasive techniques for the detection of coronary artery disease?. Arterioscler Thromb Vasc Biol 2014; 34 (7) 1341-1345
    CrossrefPubMedGoogle Scholar
  • 22 Nelemans PJ, Leiner T, de Vet HC, van Engelshoven JM. Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology 2000; 217 (1) 105-114
    CrossrefPubMedGoogle Scholar
  • 23 Cilingiroglu M, Hakeem A, Feldman M, Wholey M. Optical coherence tomography imaging in asymptomatic patients with carotid artery stenosis. Cardiovasc Revasc Med 2013; 14 (1) 53-56
    CrossrefPubMedGoogle Scholar
  • 24 Sukhija R, Aronow WS, Yalamanchili K, Peterson SJ, Frishman WH, Babu S. Association of ankle-brachial index with severity of angiographic coronary artery disease in patients with peripheral arterial disease and coronary artery disease. Cardiology 2005; 103 (3) 158-160
    CrossrefPubMedGoogle Scholar
  • 25 Amarenco P, Bogousslavsky J, Callahan III A , et al; Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355 (6) 549-559
    CrossrefPubMedGoogle Scholar
  • 26 Adams RJ, Albers G, Alberts MJ , et al; American Heart Association; American Stroke Association. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 2008; 39 (5) 1647-1652
    CrossrefPubMedGoogle Scholar
  • 27 Qi Y, Fan J, Liu J , et al. Cholesterol-overloaded HDL particles are independently associated with progression of carotid atherosclerosis in a cardiovascular disease-free population: a community-based cohort study. J Am Coll Cardiol 2015; 65 (4) 355-363
    CrossrefPubMedGoogle Scholar
  • 28 Sala-Vila A, Romero-Mamani ES, Gilabert R , et al. Changes in ultrasound-assessed carotid intima-media thickness and plaque with a Mediterranean diet: a substudy of the PREDIMED trial. Arterioscler Thromb Vasc Biol 2014; 34 (2) 439-445
    CrossrefPubMedGoogle Scholar
  • 29 Tripolt NJ, Narath SH, Eder M, Pieber TR, Wascher TC, Sourij H. Multiple risk factor intervention reduces carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol 2014; 13: 95
    CrossrefPubMedGoogle Scholar
  • 30 Balk EM, Karas RH, Jordan HS, Kupelnick B, Chew P, Lau J. Effects of statins on vascular structure and function: a systematic review. Am J Med 2004; 117 (10) 775-790
    CrossrefPubMedGoogle Scholar
  • 31 Howard BV, Roman MJ, Devereux RB , et al. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA 2008; 299 (14) 1678-1689
    CrossrefPubMedGoogle Scholar
  • 32 Sytkowski PA, Kannel WB, D'Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med 1990; 322 (23) 1635-1641
    CrossrefPubMedGoogle Scholar
  • 33 Whayne TF. Evaluation critique of state of the art dyslipidemia management in general and with a special emphasis on the Indian population. Indian Heart J 2007; 59 (3) 218-225
    PubMedGoogle Scholar
  • 34 Ballantyne CM. Cholesterol, lipids, and statins. Tex Heart Inst J 2005; 32 (3) 378-379
    PubMedGoogle Scholar
  • 35 Patel A, MacMahon S, Chalmers J , et al; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358 (24) 2560-2572
    CrossrefPubMedGoogle Scholar
  • 36 Gerstein HC, Miller ME, Byington RP , et al; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358 (24) 2545-2559
    CrossrefPubMedGoogle Scholar
  • 37 Takamiya T, Zaky WR, Edmundowics D , et al. World Health Organization-defined metabolic syndrome is a better predictor of coronary calcium than the adult treatment panel III criteria in American men aged 40–49 years. Diabetes Care 2004; 27 (12) 2977-2979
    CrossrefPubMedGoogle Scholar
  • 38 Balkau B, Charles MA ; European Group for the Study of Insulin Resistance (EGIR). Comment on the provisional report from the WHO consultation. Diabet Med 1999; 16 (5) 442-443
    CrossrefPubMedGoogle Scholar
  • 39 A new worldwide definition of the metabolic syndrome: Consensus from the International Diabetes Federation could help stop the cardiovascular disease time bomb [press release]. Berlin, German: International Diabetes Federation; April 14, 2005
    PubMedGoogle Scholar
  • 40 Adolphe A, Cook LS, Huang X. A cross-sectional study of intima-media thickness, ethnicity, metabolic syndrome, and cardiovascular risk in 2268 study participants. Mayo Clin Proc 2009; 84 (3) 221-228
    CrossrefPubMedGoogle Scholar
  • 41 Wiviott SD, Cannon CP, Morrow DA, Ray KK, Pfeffer MA, Braunwald E ; PROVE IT-TIMI 22 Investigators. Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. J Am Coll Cardiol 2005; 46 (8) 1411-1416
    CrossrefPubMedGoogle Scholar
  • 42 Whayne Jr TF. Is there a problem with ezetimibe or just ENHANCEd hype?. Angiology 2008; 59 (6) 661-663
    CrossrefPubMedGoogle Scholar
  • 43 Mikhailidis DP, Sibbring GC, Ballantyne CM, Davies GM, Catapano AL. Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy. Curr Med Res Opin 2007; 23 (8) 2009-2026
    CrossrefPubMedGoogle Scholar
  • 44 Stalenhoef AF. The benefit of statins in non-cardiac vascular surgery patients. J Vasc Surg 2009; 49 (1) 260-265
    CrossrefPubMedGoogle Scholar
  • 45 Heyer EJ, Mergeche JL, Bruce SS , et al. Statins reduce neurologic injury in asymptomatic carotid endarterectomy patients. Stroke 2013; 44 (4) 1150-1152
    CrossrefPubMedGoogle Scholar
  • 46 Alhusban A, Fagan SC. Secondary prevention of stroke in the elderly: a review of the evidence. Am J Geriatr Pharmacother 2011; 9 (3) 143-152
    CrossrefPubMedGoogle Scholar
  • 47 Spence JD. Asymptomatic carotid stenosis: mainly a medical condition. Vascular 2010; 18 (3) 123-126 , discussion 127–129
    CrossrefPubMedGoogle Scholar
  • 48 Schneider PA, Naylor AR. Transatlantic debate. Asymptomatic carotid artery stenosis—medical therapy alone versus medical therapy plus carotid endarterectomy or stenting. Eur J Vasc Endovasc Surg 2010; 40 (2) 274-281
    CrossrefPubMedGoogle Scholar
  • 49 Ederle J, Brown MM. The evidence for medicine versus surgery for carotid stenosis. Eur J Radiol 2006; 60 (1) 3-7
    CrossrefPubMedGoogle Scholar
  • 50 van Kuijk JP, Flu WJ, Welten GM , et al. Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease. Eur Heart J 2010; 31 (8) 992-999
    CrossrefPubMedGoogle Scholar
  • 51 Welten GM, Schouten O, Hoeks SE , et al. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol 2008; 51 (16) 1588-1596
    CrossrefPubMedGoogle Scholar
  • 52 Grundy SM, Cleeman JI, Merz CN , et al; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110 (2) 227-239
    CrossrefPubMedGoogle Scholar